Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.815 USD | +1.40% | -1.08% | -37.97% |
May. 09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.97% | 67.18M | |
+8.03% | 114B | |
+9.30% | 104B | |
-1.02% | 22.57B | |
-11.66% | 22.5B | |
-10.23% | 17.95B | |
-41.90% | 16.48B | |
-14.67% | 15.82B | |
+2.54% | 13.55B | |
+28.00% | 10.99B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- BioXcel Therapeutics Says Combination Treatment Showed 'Encouraging Response Rate' in Prostate Cancer Phase 2 Trial